Intracellular aggregation of α-synuclein is a pathological hallmark of Lewy body spectrum disorders (LBSD), a heterogeneous group of neurodegenerative diseases that includes Parkinson’s disease (PD), Parkinson’s disease with dementia (PDD), and dementia with Lewy bodies (DLB). Here, SNCA is linked to Lewy body dementia.